Rockwell Automation's PharmaSuite Boosts Sintetica's Drug Production

Rockwell Automation Inc. (NYSE: ROK) is a top manufacturing stock recommended by hedge funds. Sintetica, a Swiss pharmaceutical company, implemented Rockwell’s FactoryTalk PharmaSuite MES on June 26 to improve production quality and speed up time to market for anesthesia, pain management, and other therapies.

Technicians at Sintetica’s Swiss facility worked with Rockwell Automation consultants to integrate PharmaSuite, resulting in positive feedback on increased efficiency from operators. Rockwell Automation Inc. provides industrial automation and digital transformation solutions globally, with potential investment opportunities in AI stocks offering greater upside potential.

For more insights on potential investments, check out 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. This article was originally published on Insider Monkey.

Read more at Yahoo Finance: Rockwell Automation’s PharmaSuite Powers Sintetica’s Swiss Drug Production